Stopping Wegovy or Zepbound: can you keep the weight off?

Most people regain some weight after stopping, so it's worth planning before you stop. In trials, people regained about two-thirds of their lost weight in the year after stopping semaglutide, and people taken off tirzepatide regained much of theirs. No tapering schedule has been proven yet. Regular exercise has trial support, and a lower dose or a daily pill are options to discuss with your physician.

Reviewed by Darshan Patel, MD, Obesity medicine physician, on 2026-11-12. Next review 2027-05-11.

Book my consultation Video consultations with an obesity medicine physician. Most major insurance accepted, plus convenient cash pay options.

First, regain isn't a willpower problem

If you've stopped a GLP-1 before and watched the weight creep back, you didn't fail. When weight comes off, the body adapts: hunger signals come back, and the body burns a little less energy. A 2026 review of the research put it plainly: weight returning after stopping reflects biological adaptations to weight loss.

Knowing that changes how you plan. The goal is to stop, if you stop, with the odds on your side.

What the trials found after people stopped

• Semaglutide (the medicine in Wegovy). In the STEP 1 trial extension, people lost 17.3% of their body weight over 68 weeks. Then the medicine and the lifestyle program both stopped. A year later they had regained about two-thirds of what they'd lost, ending about 5.6% below where they started.
• Tirzepatide (the medicine in Zepbound). In SURMOUNT-4, people lost an average of 20.9% over 36 weeks. Those switched to placebo regained 14% of their body weight over the next year, and were still 9.9% below their starting weight at the end.
• Across many studies. A 2026 review of 37 studies found an average regain of about 0.4 kg a month after people stopped a weight medicine, faster than after diet-and-behavior programs.

So most people regain some weight, and many keep part of their loss. The steps below are about keeping more of it.

Is tapering better than stopping all at once?

It may feel gentler, but no tapering schedule has been shown to prevent regain. Two recent reviews say the evidence for tapering, and for diet or medicine changes after stopping, is still limited.

What has been tested is staying on something rather than nothing:

• A lower dose. In SURMOUNT-MAINTAIN, people who stepped down to a lower dose of tirzepatide kept more of their weight loss than people switched to placebo, though less than people who stayed on their full dose. Over the whole trial, they ended 16.6% below their starting weight, compared with 9.9% on placebo and 21.9% on the full dose.
• A daily pill. In ATTAIN-MAINTAIN, people who switched from tirzepatide or semaglutide injections to orforglipron, a once-daily GLP-1 pill, kept about 75% to 79% of their weight loss a year later, compared with about 38% to 49% on placebo.

Whether either fits you depends on your health, your goals and your coverage. That's a conversation for your physician, not a schedule to try on your own.

What helps you hold on to more of it

1. Exercise, ideally started while you're still on the medicine. In a Danish trial, people who lost weight and then spent a year in a supervised exercise program, with or without the GLP-1 liraglutide, held on to more of their loss. A year after treatment ended, people who had combined exercise with liraglutide had kept off about 5.1 kg more than people who took liraglutide alone. A 2026 review concluded that structured exercise may help reduce regain and preserve lean mass.
2. Protect your muscle now. Strength training and enough protein while you're losing help more of the weight you lose be fat rather than muscle. See keeping muscle on a GLP-1.
3. Keep protein at every meal. Build the habit now, while your care team is checking in, so it's already part of your routine if you stop. See how much protein you need.
4. Keep your check-ins. Weigh yourself regularly and agree with your physician on a number that means "let's talk." A 2026 review recommends treating the months after stopping as a time for closer follow-up, not the end of care.
5. Know your options before you need them. Restarting, a lower dose or a different medicine are all on the table if the weight starts coming back.

Still deciding whether to stop at all? Do I have to take a GLP-1 forever? walks through what happens when people keep going.

A plan for the long game

At Aayu Well, an obesity medicine physician sees you by video and plans with you from the start for keeping the weight off, including what happens if you stop. A registered dietitian helps you protect muscle and build meals you'll keep eating, and your care team is a message away between visits. We prescribe GLP-1 medicines when they're right for you, and we help you change course when your life changes.

Most major insurance accepted, plus convenient cash pay options. Book my consultation

Good to know

• Plan any stop, pause, restart or dose change with your prescriber.
• If you're planning a pregnancy, the Wegovy label advises stopping it at least 2 months beforehand, and the Zepbound label advises stopping when a pregnancy is recognized.
• The trials in this guide studied the brand-name medicines along with diet and activity changes. Results vary from person to person.

More physician-reviewed guides are in Learn, and our editorial policy explains how we choose sources and grade evidence.

Questions people ask

Can Aayu Well help me come off my GLP-1, or stay on it?

Yes, either way. Your obesity medicine physician reviews how far you've come, why you're thinking of stopping and what your options are, then builds a plan with you. A registered dietitian helps you protect muscle and eat enough protein, and your care team checks in as things change. Most major insurance accepted, plus convenient cash pay options.

How fast does the weight come back?

It varies a lot from person to person. A 2026 review of 37 studies found an average regain of about 0.4 kg, a little under a pound, a month after people stopped a weight medicine. That was faster than after diet-and-behavior programs.

Should I taper off instead of stopping all at once?

No tapering schedule has been proven to prevent regain yet. What has been tested is staying on a lower dose of tirzepatide, which kept more weight off than stopping, and switching from an injection to a daily GLP-1 pill. Your physician can help you weigh those options.

Will my blood pressure and blood sugar change if I stop?

They may. In the STEP 1 trial extension, most of the improvements in heart and metabolic health measures drifted back toward where they started in the year after people stopped semaglutide. That's one reason to keep checking in with your physician after you stop.

I'm planning a pregnancy. Do I need to stop?

Yes, and the timing matters. The Wegovy label advises stopping at least 2 months before a planned pregnancy, and the Zepbound label advises stopping when a pregnancy is recognized. Talk with your physician so you can plan it together.

Sources

1. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564
2. Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48
3. West S, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ. 2026;392:e085304
4. Shah E, et al. Clinical management of weight regain and cardiometabolic consequences after discontinuation of GLP-1 receptor agonists. Diabetes Obes Metab. 2026;28(6):4546-4558
5. Marchetti M, et al. Weight regain after discontinuation of GLP-1 and GIP/GLP-1 receptor agonists: a systematic review. Metabolites. 2026;16(10):757
6. Horn DB, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity (SURMOUNT-MAINTAIN). Lancet. 2026;407(10545):2305-2318
7. Aronne LJ, et al. Orforglipron for maintenance of body weight reduction (ATTAIN-MAINTAIN). Nat Med. 2026;32(7):2679-2687
8. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. Obesity Pillars. 2025;15:100181
9. Lundgren JR, et al. Healthy weight loss maintenance with exercise, liraglutide, or both combined. N Engl J Med. 2021;384(18):1719-1730
10. Jensen SBK, et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment. eClinicalMedicine. 2024;69:102475
11. Wegovy (semaglutide) prescribing information, DailyMed, revised 6/2026
12. Zepbound (tirzepatide) prescribing information, DailyMed, revised 8/2026